1 May 2025

Last updated: Tuesday 29 April 2025

Research Directory

European biotechs start to look undervalued

An interview with Thomas Lönngren -- Managing change at the EMA

JAK2 inhibitors: a breakthrough in oncology?

European Commission lifts funding for innovation

Boehringer Ingelheim opts for nimble approach

Affimed brings new antibody to the clinic

$2 billion in new US funding

Competition intensifies for cancer treatments

When is the right time for Pharma to develop stem cell technology

Cannabis medicines approved by regulator